This potentially powerful combination treatment of ALDH1A1-siRNA and GEM warrants further investigation as an effective therapeutic regimen to overcome the resistance of pancreatic cancer to GEM. The gene discussed is ALDH1A1; the disease is familial pancreatic carcinoma.